BOPCF Stock: BioPharma Credit PLC Stock Price, Analysis & Insights
Get live BOPCF stock price $0.91, comprehensive BioPharma Credit PLC stock analysis, charts, news, and expert forecast. Real-time BOPCF stock data and investment insights.
Loading chart data...
BioPharma Credit PLC (BOPCF) Overview
BioPharma Credit PLC (BOPCF) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, BOPCF trades at $0.91 with a market capitalization of 1.02B . Over the past 52 weeks, BOPCF has traded between $0.84 and $1.02 , with the current price positioned at approximately 39% of this range . The stock currentl...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 1.02B
- Current price: $0.91
- 52-week range: $0.84 - $1.02
- P/E ratio: 14.64
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale ...
Company Information
- CEO
- Pedro Gonzalez de Cosio
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- 0
Contact Information
- Website
- https://www.bpcruk.com
- Address
- 51 New North Road
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 14.6)
✓ Lower volatility stock (Beta: 0.18) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BioPharma Credit PLC shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for BioPharma Credit PLC
- ⚠Investors should consider how BioPharma Credit PLC fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.02B
P/E Ratio (TTM)
14.64
Beta
0.18
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BOPCF with peer companies:
- Price
- $2.12
- Market cap
- 1.17B
- Price
- $1.03
- Market cap
- 996.06M
- Price
- $49.40
- Market cap
- 1.21B
- Price
- $2.75
- Market cap
- 908.53M
- Price
- $1.30
- Market cap
- 871.94M
- Price
- $49.48
- Market cap
- 889.26M
- Price
- $29.10
- Market cap
- 1.30B
- Price
- $11.33
- Market cap
- 976.97M
- Price
- $3.42
- Market cap
- 1.12B
- Price
- $10.25
- Market cap
- 1.15B
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.